Other signaling pathways, including Smad signaling, PI3K/mTOR, Notch, and the β-catenin pathway, have also been implicated in NIS repression in thyroid cancer, and might be potential targets for “redifferentiation” strategies [23]. Here, SLC5A5 is linked to thyroid cancer.